Abstract |
Multigene-based combination therapy is an effective practice in cancer gene therapy. Apoptin is a chicken anemia virus-derived, p53-independent, Bcl-2-insensitive apoptotic protein with the ability to specifically induce apoptosis in various human tumor cells. Interleukin-24 (IL-24) displays ubiquitous antitumor property and tumor-specific killing activity. Adeno-associated virus (AAV) is a promising gene delivery vehicle due to its advantage of low pathogenicity and long-term gene expression. In this study, we assessed the efficacy of combination therapy using AAV-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma in vitro and in vivo. Our results showed that AAV-mediated co-expression of IL-24 and apoptin significantly suppressed the growth and induced the apoptosis of HepG2 cells in vitro. Furthermore, AAV-mediated combined treatment of IL-24 and apoptin significantly suppressed tumor growth and induced apoptosis of tumor cells in xenograft nude mice. These data suggest that AAV vectors that co-express apoptin and IL-24 have great potential in cancer gene therapy.
|
Authors | Lijie Yuan, Hengyu Zhao, Liqiu Zhang, Xinghan Liu |
Journal | Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
(Tumour Biol)
Vol. 34
Issue 5
Pg. 3027-34
(Oct 2013)
ISSN: 1423-0380 [Electronic] Netherlands |
PMID | 23907578
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apoptosis Regulatory Proteins
- Capsid Proteins
- Interleukins
- VP3 protein, Chicken anemia virus
- interleukin-24
|
Topics |
- Animals
- Apoptosis
- Apoptosis Regulatory Proteins
(metabolism)
- Capsid Proteins
(biosynthesis, genetics)
- Carcinoma, Hepatocellular
(metabolism, pathology, therapy)
- Dependovirus
(genetics)
- Gene Expression
- Genetic Therapy
- Genetic Vectors
- Hep G2 Cells
- Humans
- Interleukins
(biosynthesis, genetics)
- Liver Neoplasms
(metabolism, pathology, therapy)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Transplantation
- Tumor Burden
|